Quantum BioPharma engages Enterprise Canada, Empire for PR, investor programs

Quantum BioPharma has retained the services of Enterprise Canada and Empire Market Ventures to lead its comprehensive public relations and investor awareness programs, respectively, across all key markets. Enterprise has been engaged for an indefinite period effective December 18. The Enterprise Agreement is structured in three phases, with C$10,000 paid to Enterprise at the start of Phase 1, C$2,500 on the completion of Phase 1, and C$5,000 due monthly as a public relations retainer. Enterprise will be assisting the Company with its public relations strategy, which includes developing the Company’s narrative, key messages, and pitching strategies with identified targets. Also, Enterprise will provide the Company with ongoing public relationships support, which includes building relationships with media, story ideation, and pitching for specific projects or initiatives. Empire has been engaged for a period of three months, effective February 7. Pursuant to the Empire Agreement, the Company paid Empire a total of $25,000 in fees. Empire will be providing the Company with investor awareness and marketing services, which includes giving the Company access to an exclusive NASDAQ, TSX, and ASX mailing list and investor contacts, content creation, media appearances, branding and consulting, and other services aimed at increasing the Company’s engagement with investors.